Am J Perinatol
DOI: 10.1055/a-1925-9972
Original Article

Severe Maternal Morbidity among Low-Income Patients with Hypertensive Disorders of Pregnancy

1   Department of Health Policy and Organization, School of Public Health, The University of Alabama at Birmingham, Birmingham, Alabama
,
Sara E. Mazzoni*
2   Department of Obstetrics and Gynecology, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama
,
Martha S. Wingate
1   Department of Health Policy and Organization, School of Public Health, The University of Alabama at Birmingham, Birmingham, Alabama
,
Janet M. Bronstein
1   Department of Health Policy and Organization, School of Public Health, The University of Alabama at Birmingham, Birmingham, Alabama
› Author Affiliations
Funding This study was supported by DHHS, HRSA, MCHB grant no.: T76MC00008, NIH, and NCATS grant no.: TL1 TR 003106.

Abstract

Objective Hypertensive disorders of pregnancy (HDP) contribute significantly to the development of severe maternal morbidities (SMM), particularly among low-income women. The purpose of the study was to explore the relationship between maternal characteristics and SMM, and to investigate if differences in SMM exist among patients with HDP diagnosis.

Study Design This study utilized 2017 Alabama Medicaid administrative claims. SMM diagnoses were captured using the Centers for Disease Control and Prevention's classification by International Classification of Diseases codes. Maternal characteristics and frequencies were compared using Chi-square and Cramer's V statistics. Logistic regression analyses were conducted to examine multivariable relationships between maternal characteristics and SMM among patients with HDP diagnosis. Odds ratios and 95% confidence intervals (CIs) were used to estimate risk.

Results A higher proportion of patients experiencing SMM were >34 years old, Black, Medicaid for Low-Income Families eligible, lived in a county with greater Medicaid enrollment, and entered prenatal care (PNC) in the first trimester compared with those without SMM. Almost half of patients (46.2%) with SMM had a HDP diagnosis. After controlling for maternal characteristics, HDP, maternal age, county Medicaid enrollment, and trimester PNC entry were not associated with SMM risk. However, Black patients with HDP were at increased risk for SMM compared with White patients with HDP when other factors were taken into account (adjusted odds ratio [aOR] = 1.37, 95% CI: 1.11–1.69). Patients with HDP and SMM were more likely to have a prenatal hospitalization (aOR = 1.45, 95% CI: 1.20–1.76), emergency visit (aOR = 1.30, 95% CI: 1.07–1.57), and postpartum cardiovascular prescription (aOR = 2.43, 95% CI: 1.95–3.04).

Conclusion Rates of SMM differed by age, race, Medicaid income eligibility, and county Medicaid enrollment but were highest among patients with clinical comorbidities, especially HDP. However, among patients with HDP, Black patients had an elevated risk of severe morbidity even after controlling for other characteristics.

Key Points

  • Patients with SMM were more likely to have a HDP diagnosis.

  • Among those with HDP, Black patients had elevated risk of SMM.

  • Differences in care delivery did not explain SMM disparities.

Note

These sponsors/funding sources had no involvement in any aspect of this study.


* Present address: University of Washington School of Medicine, Department of Obstetrics and Gynecology, 325 Ninth Avenue Box 359865, Seattle, WA 98104.




Publication History

Received: 14 June 2021

Accepted: 11 August 2022

Accepted Manuscript online:
17 August 2022

Article published online:
30 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Kilpatrick SK, Ecker JL.. American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine. Severe maternal morbidity: screening and review. Am J Obstet Gynecol 2016; 215 (03) B17-B22
  • 2 Creanga AA, Berg CJ, Ko JY. et al. Maternal mortality and morbidity in the United States: where are we now?. J Womens Health (Larchmt) 2014; 23 (01) 3-9
  • 3 Campbell KH, Savitz D, Werner EF. et al. Maternal morbidity and risk of death at delivery hospitalization. Obstet Gynecol 2013; 122 (03) 627-633
  • 4 Small MJ, James AH, Kershaw T, Thames B, Gunatilake R, Brown H. Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care unit admissions. Obstet Gynecol 2012; 119 (2, Pt 1): 250-255
  • 5 Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol 2011; 118 (01) 29-38
  • 6 Lu MC, Highsmith K, de la Cruz D, Atrash HK. Putting the “M” back in the Maternal and Child Health Bureau: reducing maternal mortality and morbidity. Matern Child Health J 2015; 19 (07) 1435-1439
  • 7 Hitti J, Sienas L, Walker S, Benedetti TJ, Easterling T. Contribution of hypertension to severe maternal morbidity. Am J Obstet Gynecol 2018; 219 (04) 405.e1-405.e7
  • 8 Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22 (02) 203-212
  • 9 Kolte D, Khera S, Aronow WS. et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 2014; 3 (03) e001056
  • 10 Schutte JM, Schuitemaker NW, van Roosmalen J, Steegers EA. Dutch Maternal Mortality Committee. Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG 2008; 115 (06) 732-736
  • 11 Ackerman CM, Platner MH, Spatz ES. et al. Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization. Am J Obstet Gynecol 2019; 220 (06) 582.e1-582.e11
  • 12 Geller SE, Rosenberg D, Cox SM. et al. The continuum of maternal morbidity and mortality: factors associated with severity. Am J Obstet Gynecol 2004; 191 (03) 939-944
  • 13 Gray KE, Wallace ER, Nelson KR, Reed SD, Schiff MA. Population-based study of risk factors for severe maternal morbidity. Paediatr Perinat Epidemiol 2012; 26 (06) 506-514
  • 14 Johnson PD, Duzyj CM, Howell EA, Janevic T. Patient and hospital characteristics associated with severe maternal morbidity among postpartum readmissions. J Perinatol 2019; 39 (09) 1204-1212
  • 15 Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol 2008; 199 (02) 133.e1-133.e8
  • 16 Metcalfe A, Wick J, Ronksley P. Racial disparities in comorbidity and severe maternal morbidity/mortality in the United States: an analysis of temporal trends. Acta Obstet Gynecol Scand 2018; 97 (01) 89-96
  • 17 Holdt Somer SJ, Sinkey RG, Bryant AS. Epidemiology of racial/ethnic disparities in severe maternal morbidity and mortality. Semin Perinatol 2017; 41 (05) 258-265
  • 18 Liese KL, Mogos M, Abboud S, Decocker K, Koch AR, Geller SE. Racial and ethnic disparities in severe maternal morbidity in the United States. J Racial Ethn Health Disparities 2019; 6 (04) 790-798
  • 19 Greiner KS, Speranza RJ, Rincón M, Beeraka SS, Burwick RM. Association between insurance type and pregnancy outcomes in women diagnosed with hypertensive disorders of pregnancy. J Matern Fetal Neonat Med 2020; 33 (08) 1427-1433
  • 20 Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21 (05) 521-526
  • 21 Singh GK, Siahpush M, Liu L, Allender M. Racial/ethnic, nativity, and sociodemographic disparities in maternal hypertension in the United States. Int J Hypertens 2018; 2018: 7897189
  • 22 Miranda ML, Swamy GK, Edwards S, Maxson P, Gelfand A, James S. Disparities in maternal hypertension and pregnancy outcomes: evidence from North Carolina, 1994-2003. Public Health Rep 2010; 125 (04) 579-587
  • 23 Shahul S, Tung A, Minhaj M. et al. Racial disparities in comorbidities, complications, and maternal and fetal outcomes in women with preeclampsia/eclampsia. Hypertens Pregnancy 2015; 34 (04) 506-515
  • 24 Jones EJ, Hernandez TL, Edmonds JK, Ferranti EP. Continued disparities in postpartum follow-up and screening among women with gestational diabetes and hypertensive disorders of pregnancy: a systematic review. J Perinat Neonatal Nurs 2019; 33 (02) 136-148
  • 25 Jessica Ravitz J. . Alabama says it wants to protect life. How does that claim stack up outside the womb? Published 2019. Accessed August 30, 2022 at: https://www.cnn.com/2019/05/16/health/alabama-treatment-of-living/index.html
  • 26 Markus AR, Andres E, West KD, Garro N, Pellegrini C. Medicaid covered births, 2008 through 2010, in the context of the implementation of health reform. Womens Health Issues 2013; 23 (05) e273-e280
  • 27 Bennett WL, Chang H-Y, Levine DM. et al. Utilization of primary and obstetric care after medically complicated pregnancies: an analysis of medical claims data. J Gen Intern Med 2014; 29 (04) 636-645
  • 28 Guglielminotti J, Landau R, Wong CA, Li G. Patient-, hospital-, and neighborhood-level factors associated with severe maternal morbidity during childbirth: a cross-sectional study in New York state 2013-2014. Matern Child Health J 2019; 23 (01) 82-91
  • 29 The Centers for Disease Control and Prevention. Severe maternal morbidity indicators and corresponding ICD codes during delivery hospitalizations. Published 2019. Accessed August 6, 2019 at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm
  • 30 Olives C, Myerson R, Mokdad AH, Murray CJL, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One 2013; 8 (04) e60308-e60308
  • 31 Alabama Medicaid Agency. FY 2017 Annual Report. Accessed December 20, 2022 at: https://medicaid.alabama.gov/content/2.0_newsroom/2.3_Publications/2.3.2_Report_Archive.aspx 2017
  • 32 Alabama Rural Health Association. Analysis of urban vs. rural. Accessed January 31, 2020, at: https://arhaonline.org/analysis-of-urban-vs-rural/
  • 33 McEvoy GK. AHFS Drug Information Essentials. Bethesda, MA: American Society of Health-System Pharmacists; 2011
  • 34 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108
  • 35 Grimes DA, Schulz KF. Making sense of odds and odds ratios. Obstet Gynecol 2008; 111 (2, Pt 1): 423-426
  • 36 Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113 (06) 1299-1306
  • 37 Howell EA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol 2018; 61 (02) 387-399
  • 38 Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol 2010; 202 (04) 335-343
  • 39 Admon LK, Winkelman TNA, Moniz MH, Davis MM, Heisler M, Dalton VK. Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005-2014. Obstet Gynecol 2017; 130 (06) 1319-1326
  • 40 Creanga AA, Bateman BT, Kuklina EV, Callaghan WM. Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008-2010. Am J Obstet Gynecol 2014; 210 (05) 435.e1-435.e8
  • 41 Howland RE, Angley M, Won SH. et al. Determinants of severe maternal morbidity and its racial/ethnic disparities in New York City, 2008–2012. Matern Child Health J 2019; 23 (03) 346-355
  • 42 Witzig R. The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med 1996; 125 (08) 675-679
  • 43 Attanasio L, Kozhimannil KB. Patient-reported communication quality and perceived discrimination in maternity care. Med Care 2015; 53 (10) 863-871
  • 44 Slaughter-Acey JC, Caldwell CH, Misra DP. The influence of personal and group racism on entry into prenatal care among African American women. Womens Health Issues 2013; 23 (06) e381-e387
  • 45 Conway KS, Kutinova A. Maternal health: does prenatal care make a difference?. Health Econ 2006; 15 (05) 461-488
  • 46 Admon LK, Winkelman TNA, Zivin K, Terplan M, Mhyre JM, Dalton VK. Racial and ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012–2015. Obstet Gynecol 2018; 132 (05) 1158-1166
  • 47 Brown HL, Small M, Taylor YJ, Chireau M, Howard DL. Near miss maternal mortality in a multiethnic population. Ann Epidemiol 2011; 21 (02) 73-77
  • 48 Howell EA, Egorova N, Balbierz A, Zeitlin J, Hebert PL. Black-white differences in severe maternal morbidity and site of care. Am J Obstet Gynecol 2016; 214 (01) 122.e1-122.e7
  • 49 Laditka SB, Laditka JN, Probst JC. Racial and ethnic disparities in potentially avoidable delivery complications among pregnant Medicaid beneficiaries in South Carolina. Matern Child Health J 2006; 10 (04) 339-350
  • 50 Boulet SL, Platner M, Joseph NT. et al. Hypertensive disorders of pregnancy, cesarean delivery, and severe maternal morbidity in an urban safety-net population. Am J Epidemiol 2020; 189 (12) 1502-1511
  • 51 Taylor JK. Structural racism and maternal health among black women. J Law Med Ethics 2020; 48 (03) 506-517
  • 52 Declercq ER, Belanoff C, Sakala C. Intrapartum care and experiences of women with midwives versus obstetricians in the Listening to Mothers in California Survey. J Midwifery Womens Health 2020; 65 (01) 45-55
  • 53 Henry J, Foundation KF. Status of state Medicaid expansion decisions: interactive map. Published 2020. Accessed October 22, 2020 at: https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/
  • 54 Lain SJ, Hadfield RM, Raynes-Greenow CH. et al. Quality of data in perinatal population health databases: a systematic review. Med Care 2012; 50 (04) e7-e20
  • 55 Funk MJ, Landi SN. Misclassification in administrative claims data: quantifying the impact on treatment effect estimates. Curr Epidemiol Rep 2014; 1 (04) 175-185
  • 56 Main EK, Abreo A, McNulty J. et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol 2016; 214 (05) 643.e1-643.e10
  • 57 Wolf M, Shah A, Jimenez-Kimble R, Sauk J, Ecker JL, Thadhani R. Differential risk of hypertensive disorders of pregnancy among Hispanic women. J Am Soc Nephrol 2004; 15 (05) 1330-1338
  • 58 Oates GR, Jackson BE, Partridge EE, Singh KP, Fouad MN, Bae S. Sociodemographic patterns of chronic disease: how the mid-south region compares to the rest of the country. Am J Prev Med 2017; 52 (1S1): S31-S39